There is always the chance for another update on the cancer front as this is an ongoing process. Maybe something is compiled to be announced soon. If so, there are enough people involved to have one or two outside the management team to buy before the anns. The market has been informed about not just killing the tumor cells but about triggering an immune system response as well - the holy grail. And still the only company in the world I have read about achieving the same in pre-clinical trials is City of Hope / ASX listed IMU with its OV CF 33.
The market had enough time to buy, maybe someone finally put one and one together.
GLTA
IVX Price at posting:
1.1¢ Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)